A Phase 1, Open-label, 2-period Fixed-sequence Study to Evaluate the Effect of Multiple Doses of SHP620 (Maribavir) on the Pharmacokinetics of Digoxin and Dextromethorphan in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Maribavir (Primary) ; Dextromethorphan; Digoxin
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- Sponsors Shire
- 20 Sep 2016 Status changed from recruiting to completed.
- 24 Aug 2016 Status changed from not yet recruiting to recruiting.
- 21 May 2016 New trial record